A PRAM image in which each black dot represents one detected COVID-19 antibody molecule. (Credit: University of Illinois)

A cost-efficient COVID-19 antibody test costs less than $2 per test and is used with a desktop detection system that is suitable for point-of-care situations like clinics and physician offices.

The test requires only a finger-stick quantity of blood (~4 μL). The method the researchers used to detect COVID-19 antibody can also be adapted to detect other molecules, such as antibodies to other viral pathogens, biomarkers for cardiac disease, and biomarkers for cancer.

When COVID-19 began developing into a global crisis in early 2020, the research group was already working on an NIH-funded project to develop a “flu chip” that would rapidly determine the most likely cause of a fever by measuring several proteins within a droplet of blood. They decided to pivot their efforts to detect COVID-19 antibodies instead.

Serological (detected by blood sample) antibody testing is an important diagnostic tool for combating the COVID-19 pandemic. Studies have shown that measurement of SARS-CoV-2 specific antibodies may be helpful for the diagnosis of suspected patients with negative RT-PCR results and for the identification of asymptomatic infections.

For more information, visit here .


Medical Design Briefs Magazine

This article first appeared in the March, 2021 issue of Medical Design Briefs Magazine.

Read more articles from this issue here.

Read more articles from the archives here.